What’s New in Photon Counting CT?

October 17, 2026 · 11 articles · 15 research themes · covering October 10, 2026 – October 17, 2026

Overview

Across this week’s set of studies, a dominant theme is the move from “better CT images” toward more reliable, quantitative, and task-specific imaging using photon-counting/spectral detector technology. Multiple papers emphasize how acquisition and reconstruction choices materially affect diagnostic performance—whether for coronary stenosis grading (via dual-source PCD-CT acquisition-mode trade-offs), valve visualization (motion-correction reconstruction), or inner-ear/temporal bone assessment (improved contrast-to-noise and metal/implant visualization with PCD-CT). Complementing these clinical efforts, phantom and ex vivo work provides the measurement backbone—characterizing iodine detection/quantification limits and demonstrating improved temporal bone visualization—so that downstream quantitative biomarkers can be trusted.

A second major thread is radiation dose and protocol individualization. The ILD feasibility study shows tin-filtered low-dose PCCT can preserve quantitative clinical utility compared with standard-dose protocols, while ultrathin reconstructions add incremental information. In parallel, the DECT-CTPA narrative review proposes a three-tier framework for individualized low-iodine scanning in pulmonary embolism, reflecting a broader push to standardize how lower contrast/dose strategies are justified without sacrificing diagnostic accuracy.

Finally, several studies highlight the clinical promise of spectral/quantitative biomarkers for challenging differential diagnoses and stratification. PCCT spectral parameters help distinguish post-pancreatic cancer recurrence from fibrosis, and PCCT-derived vestibular aqueduct morphometrics support endotype stratification and hearing-loss prediction in Ménière’s disease. Meanwhile, radiomics “age signatures” in preclinical PCCT data appear sensitive to platform and reconstruction harmonization, underscoring that reproducible quantitative imaging will require careful standardization as these methods scale.

---

Radiomics & quantitative imaging biomarkers (including age phenotyping)

Age-associated radiomic phenotyping in mice using multi-energy photon-counting and preclinical CT: an exploratory study.

This exploratory preclinical study used multi-energy photon-counting CT (PCCT) and preclinical Albira II CT to test whether CT radiomic features reflect chronological age-associated imaging phenotypes in female C57BL/6NRj mice (28, 88, and 99 weeks). The key finding was that age-associated radiomic classification performance depends on both the imaging platform and the photon-counting CT reconstruction strategy, indicating that radiomic “age signatures” are not fully transferable across acquisition/reconstruction settings. Scientifically, this supports careful harmonization of PCCT reconstruction and platform parameters when using radiomics for age-related phenotyping in animal models.

Castioni NA, Wängler C, Mogler C et al. · Biogerontology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Low-dose and dose-reduction strategies in photon-counting CT

Low-dose vs standard-dose photon-counting CT for myopathy-associated interstitial lung disease: a prospective feasibility study.

In a single-center prospective feasibility study, outpatients with inflammatory idiopathic myopathy–associated interstitial lung disease (IIM-ILD) underwent two consecutive photon-counting CT (PCCT) scans using tin-filtered low-dose (LD) and standard-dose (SD) protocols, with ultrathin reconstructions evaluated for added value. The key finding was that PCCT-derived quantitative ILD parameters from LD protocols can retain clinical utility compared with SD while enabling dose reduction, and ultrathin reconstructions provided incremental information for ILD burden assessment. Clinically, this supports using tin-filtered low-dose PCCT with quantitative deep-learning–based analysis (ContextFlow ADVANCE Chest CT) to reduce radiation while maintaining ILD quantification performance.

Zhu Z, Xu K, Pang Y et al. · European radiology · (2026) · View on PubMed ↗

---

Spectral photon-counting CT & K-edge / element-specific imaging

Color K-edge imaging using spectral photon-counting CT with high-Z elements for lung functional imaging: A phantom study.

This phantom study assessed feasibility of color K-edge imaging using spectral photon-counting CT (SPCCT) combined with eight candidate high-Z elements (gadolinium, holmium, ytterbium, hafnium, tantalum, tungsten, gold, bismuth) for lung functional imaging. The key finding was that K-edge–based contrast and measurement accuracy (including noise, contrast-to-noise ratio, and relative percentage error) varied systematically with element choice and concentration under lung protocol conditions at 120 kVp and multiple exposure levels (50, 75, 150 mAs). This supports the technical viability of SPCCT K-edge “color” imaging for functional lung applications by demonstrating measurable, element-dependent contrast performance.

Gutwinska AJ, Rosario D, Robert A et al. · Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Iodine quantification & spectral measurement performance

Evaluation of iodine detection and quantification limits in photon-counting CT-a phantom study.

This phantom study evaluated iodine detection and quantification limits in photon-counting CT (PCCT) compared with dual-energy CT (DECT) using laboratory-style test tubes containing iodine concentrations from 0.0 to 2.0 mg/mL. The key finding was that iodine measurement performance can be characterized in terms of detection threshold, quantification precision, and linearity, and these metrics differ across PCCT and DECT systems and across head versus abdominal protocols. This is significant because it provides a quantitative basis for understanding when CT iodine maps are reliable enough for clinical decision-making.

Titternes R, Poludniowski G, Brismar TB et al. · European radiology experimental · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cardiac CT angiography and valve imaging with photon-counting detectors

Improved Visualization of Heart Valves With 4D-CT Using a Novel Motion Correction Algorithm.

This retrospective study assessed whether a novel reconstruction-based motion correction algorithm improves visualization of native and prosthetic heart valves on photon-counting detector CT (PCD-CT) compared with standard reconstructions. The key finding was that motion correction reduced motion artifacts and improved image quality for valvular assessment, particularly relevant for phases of rapid cardiac motion, in 57 patients undergoing valve CT. Clinically, improved valve visualization can enhance confidence in evaluating valvular movement and pathology on PCD-CT, potentially improving diagnostic accuracy in cardiac imaging.

Zedler D, Demmert TT, Ritter A et al. · Investigative radiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Coronary CT angiography protocol optimization (dual-source PCD-CT)

Impact of Photon-Counting CT Acquisition Modes on Coronary Stenosis Assessment and Radiation Dose: A Phantom and Clinical Evaluation.

This phantom and clinical study evaluated how different acquisition modes on a first-generation dual-source photon-counting detector CT (PCD-CT) affect coronary CT angiography (cCTA) image quality, coronary stenosis grading, diagnostic accuracy, blooming, and radiation dose. The key finding was that acquisition-mode choice materially changes stenosis assessment performance and blooming behavior while also shifting radiation dose, with the study identifying trade-offs between spatial/temporal robustness and dose across the Flash (high-pitch spiral with prospective ECG gating), Sequence, Spiral, and retrospective ultra-high-resolution (UHR) spiral modes. These results support evidence-based protocol selection for PCD-CT coronary imaging to improve diagnostic reliability at lower or optimized radiation exposure.

Stein T, Lang F, Bamberg F et al. · Zeitschrift fur medizinische Physik · (2026) · View on PubMed ↗

---

Pulmonary embolism imaging with dual-energy CT (DECT-CTPA)

Dual-energy computed tomography pulmonary angiography for pulmonary embolism: a three-tier evidence framework to guide individualized low-iodine scanning.

This narrative review synthesized evidence (28 eligible studies from 2016–June 2026) on dual-energy CT pulmonary angiography (DECT-CTPA) for pulmonary embolism (PE) to build a three-tier framework for individualized low-iodine scanning. The key finding was that DECT can be positioned across tiers—image quality, diagnostic performance, and clinical outcomes/feasibility—showing that low-iodine strategies are feasible when supported by adequate vessel conspicuity and maintained diagnostic accuracy. This framework helps clinicians and researchers standardize how to select and justify low-iodine DECT-CTPA protocols for PE across heterogeneous scanners and study designs.

Jiang Q, Qian L · Diagnostic and interventional radiology (Ankara, Turkey) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Oncology surveillance and tumor-vs-fibrosis differentiation

A Pilot Study of Photon Counting CT Spectral Analysis Following Pancreatic Adenocarcinoma Resection to Differentiate Local Recurrence From Postsurgical Fibrosis.

This retrospective pilot study used photon-counting CT (PCCT) spectral analysis after pancreatic adenocarcinoma (PDAC) resection to differentiate local recurrence from benign postsurgical fibrosis in 22 patients. The key finding was that PCCT spectral parameters—derived from iodine density (I) and iodine normalized to aortic enhancement (I normalized to aortic enhancement)—showed discriminatory value between recurrent tumor and fibrosis based on radiologist-defined regions of interest and reference standards (histopathology/enlarging FDG-avid tissue vs stable/decreasing CA 19-9 with soft-tissue reduction). Clinically, this suggests PCCT spectral imaging could improve post-surgical surveillance by reducing diagnostic uncertainty between recurrence and benign fibrotic change.

Platt S, Bansal B, Bagga B et al. · Journal of computer assisted tomography · (2026) · View on PubMed ↗

---

Carotid imaging and vascular lesion characterization

Ultra-high-resolution photon-counting CT argues against a suspected bilateral carotid web: a case report.

This case report evaluated a suspected bilateral carotid web in a 75-year-old woman with transient ischemic attack using multiple carotid CTA examinations, including a stroke-protocol photon-counting detector CT (PCD-CT) and a dedicated ultra-high-resolution (UHR) PCD-CT acquisition. The key finding was that the bilateral web-like appearance could be explained by acquisition/reconstruction characteristics rather than representing a true carotid web, arguing against the initial diagnosis. This is clinically significant because it highlights how ultra-high-resolution PCD-CT can reduce false-positive carotid web interpretations that may arise from flow-related contrast mixing or reconstruction artifacts.

Ben-David E, Bogot NR, Berrebi Y et al. · Emergency radiology · (2026) · View on PubMed ↗

---

Prosthetic/implant imaging (cochlear implants, temporal bone, metal artifact management)

Improved assessment of the cochlear implant and temporal bone structures with ultra-high resolution photon-counting detector CT compared to conventional CT systems.

This ex vivo study compared photon-counting detector CT (PCD-CT) with conventional CT systems for imaging cochlear implants and temporal bone structures using three post-mortem human specimen heads. The key finding was that PCD-CT improved visualization/contrast-to-noise characteristics for bone-to-soft-tissue across multiple scan parameters (120–150 kV, tin filtration, 0.2–0.6 mm slice thickness) and reconstruction kernels compared with SOMATOM Edge, SOMATOM Force, and NAEOTOM Alpha. Scientifically and clinically, the results support PCD-CT as a superior platform for detailed temporal bone and cochlear implant assessment where conventional CT may be limited by metal-related artifacts and resolution constraints.

van der Bie J, van der Eerden AW, van den Berg AS et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · (2026) · View on PubMed ↗ · Free PDF ↗

---

Imaging endotypes and prognostic stratification in disease (e.g., Ménière’s)

Photon-counting CT based vestibular aqueduct trajectory analysis for the assessment of Ménière’s disease endotypes and hearing loss.

This retrospective study evaluated whether photon-counting CT (PCCT)–derived vestibular aqueduct (VA) morphometric parameters in 106 patients with Ménière’s disease (212 ears) could identify imaging endotypes and predict hearing loss, using PCCT of the temporal bone alongside 3.0-T 3D-FLAIR MRI. PCCT metrics including the angular trajectory of the VA (ATVA), VA visibility grade, morphologic subtype, and midpoint width were used as imaging biomarkers to distinguish MD endotypes and relate to measures of hearing impairment. These findings suggest PCCT-based VA trajectory analysis could support endotype stratification and more personalized prognostic assessment in Ménière’s disease.

Wang J, Han Y, Xiang Y et al. · European journal of radiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

---

Generated automatically on October 17, 2026. Covers PubMed articles published October 10, 2026 – October 17, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.